AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11422884 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 7
Study 11422884 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg
Number of subjects: 7
Study 11422884 — intervention group
Group type: COMPARATOR
Intervention: Triazolam 0.125 mg
Number of subjects: 7
Study 11422884 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (all doses)
Number of subjects: 7
Study 9548039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with intravenous midazolam (5 mg for those under 65 years or 3 mg for those aged 65 or more)
Number of subjects: 100
Study 9548039 — intervention group
Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 100
Study 29948282 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Ca[OH]2)
Number of subjects: 60
Study 29948282 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) gel
Number of subjects: 60
Study 28578682 — intervention group
Group type: EXPERIMENTAL
Intervention: Group debriefings (n=26)
Number of subjects: 53
Study 28578682 — intervention group
Group type: COMPARATOR
Intervention: Leisure sessions (film viewings) (n=27)
Number of subjects: 53
Study 28578682 — intervention group
Group type: COMPARATOR
Intervention: Leisure sessions (n=27)
Number of subjects: 53
Study 28578682 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression analysis (n=48)
Number of subjects: 53
Study 26163681 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded high-velocity training (LOAD, n = 30)
Number of subjects: 57
Study 26163681 — intervention group
Group type: COMPARATOR
Intervention: Unloaded high-velocity training (UNLOAD, n = 27)
Number of subjects: 57
Study 26163681 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LOAD and UNLOAD)
Number of subjects: 57
Study 22113220 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Group A)
Number of subjects: 24
Study 22113220 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigated treatment (Group B)
Number of subjects: 24
Study 19772268 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laser photocoagulation treatment
Number of subjects: 15
Study 17324772 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine (IPB)
Number of subjects: 133
Study 17324772 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 133
Study 15196527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory gait analysis system (Physilog)
Number of subjects: 28
Study 15196527 — intervention group
Group type: COMPARATOR
Intervention: Reference motion analyzer and force plate
Number of subjects: 28
Study 12174103 — intervention group
Group type: EXPERIMENTAL
Intervention: Cipamfylline (0.15%) cream
Number of subjects: 0
Study 12174103 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 17-butyrate (0.1%) cream
Number of subjects: 0
Study 12174103 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study 9798075 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine treatment
Number of subjects: 17
Study 9798075 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol treatment
Number of subjects: 17
Study 7648380 — intervention group
Group type: EXPERIMENTAL
Intervention: Uni-Dur 800 mg once-daily
Number of subjects: 24
Study 7648380 — intervention group
Group type: EXPERIMENTAL
Intervention: Uni-Dur 400 mg twice-daily
Number of subjects: 24
Study 7648380 — intervention group
Group type: COMPARATOR
Intervention: Uniphyl 800 mg once-daily
Number of subjects: 24
Study 2704503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + norethisterone acetate 1 mg
Number of subjects: 60
Study 2704503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + megestrol acetate 5 mg
Number of subjects: 60
Study 2704503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + norethisterone acetate 0.5 mg
Number of subjects: 60
Study 2704503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + megestrol acetate 2.5 mg
Number of subjects: 60
Study 647254 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 178
Study 647254 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 178
Study 647254 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 178
Study 31894578 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 2020
Study 31894578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2020
Study 30382743 — intervention group
Group type: EXPERIMENTAL
Intervention: PREVAIL peer support intervention (n = 34)
Number of subjects: 70
Study 30382743 — intervention group
Group type: EXPERIMENTAL
Intervention: PREVAIL peer support intervention
Number of subjects: 70
Study 30382743 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 36)
Number of subjects: 70
Study 28452716 — intervention group
Group type: EXPERIMENTAL
Intervention: CK-MB levels during BPPV attack
Number of subjects: 35
Study 28452716 — intervention group
Group type: EXPERIMENTAL
Intervention: CK-MB levels before BPPV attack
Number of subjects: 35
Study 28452716 — intervention group
Group type: COMPARATOR
Intervention: CK-MB levels in control group
Number of subjects: 35
Study 25794941 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic needle (Sprotte [S])
Number of subjects: 100
Study 25794941 — intervention group
Group type: COMPARATOR
Intervention: Traumatic needle (Quincke [Q])
Number of subjects: 100
Study 23258626 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone patch for 36 months
Number of subjects: 67
Study 23258626 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch for 36 months
Number of subjects: 67
Study 21335677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycra arm splint wear combined with goal directed training
Number of subjects: 16
Study 19549428 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine/montelukast (L/M; 10 mg/10 mg)
Number of subjects: 310
Study 19549428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 17258304 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) for 48 months or more
Number of subjects: 667
Study 17258304 — intervention group
Group type: COMPARATOR
Intervention: Nonusers of inhaled corticosteroids (ICSs)
Number of subjects: 667
Study 17258304 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) for 4 years or more in subjects with high total IgE (>100 kU/L)
Number of subjects: 667
Study 17258304 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) in subjects with lower total IgE
Number of subjects: 667
Study 15606733 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream applied 5 times/week for 4 weeks
Number of subjects: 0
Study 15606733 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream applied 5 times/week for 6 weeks
Number of subjects: 0
Study 15606733 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study 15606733 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflectance-mode confocal microscopy
Number of subjects: 0
Study 11346249 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction (AMI)
Number of subjects: 40
Study 11346249 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable angina pectoris (USAP)
Number of subjects: 40
Study 11346249 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 40
Study 9554045 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconditioning
Number of subjects: 36
Study 8059725 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 468
Study 8059725 — intervention group
Group type: COMPARATOR
Intervention: Surgical therapy
Number of subjects: 468
Study 2648286 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol
Number of subjects: 15
Study 2648286 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 15
Study 2648286 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined metaproterenol and atropine
Number of subjects: 15
Study 2648286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29982765 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths-based behavioral intervention
Number of subjects: 64
Study 28526477 — intervention group
Group type: EXPERIMENTAL
Intervention: recipe card plus video modelling
Number of subjects: 141
Study 28526477 — intervention group
Group type: EXPERIMENTAL
Intervention: recipe card plus video prompting
Number of subjects: 141
Study 28526477 — intervention group
Group type: EXPERIMENTAL
Intervention: recipe card plus video elements
Number of subjects: 141
Study 28526477 — intervention group
Group type: COMPARATOR
Intervention: recipe card only
Number of subjects: 141
Study 25903358 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC videolaryngoscope
Number of subjects: 0
Study 23712737 — intervention group
Group type: EXPERIMENTAL
Intervention: levamisole (5 mg/rat/day)
Number of subjects: 22
Study 23712737 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study 23712737 — intervention group
Group type: EXPERIMENTAL
Intervention: levamisole
Number of subjects: 22
Study 22117578 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational self-management program for CHF (6 months duration, 6 nurse-directed sessions once per month)
Number of subjects: 102
Study 22117578 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment and care (Control group)
Number of subjects: 102
Study 19326108 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO(3), n = 8), 500 mg bid
Number of subjects: 15
Study 19326108 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 15
Study 19326108 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO(3)
Number of subjects: 15
Study 19326108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17728427 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg, 15 mg, 20 mg, or 30 mg)
Number of subjects: 12
Study 15054430 — intervention group
Group type: EXPERIMENTAL
Intervention: Two portions (300 g) of fruits and vegetables daily
Number of subjects: 40
Study 15054430 — intervention group
Group type: COMPARATOR
Intervention: Five portions (750 g) of fruits and vegetables daily
Number of subjects: 40
Study 15054430 — intervention group
Group type: COMPARATOR
Intervention: High intake (five portions)
Number of subjects: 40
Study 12449467 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 12449467 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 12449467 — intervention group
Group type: EXPERIMENTAL
Intervention: Different radiotherapy modalities
Number of subjects: 0
Study 12449467 — intervention group
Group type: EXPERIMENTAL
Intervention: Different types of surgery
Number of subjects: 0
Study 9695991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholate (UDC) treatment
Number of subjects: 0
Study 9695991 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 0
Study 8016587 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy laser (LEL) treatment
Number of subjects: 22
Study 8016587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 22
Study 2699615 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma domestica Val.
Number of subjects: 116
Study 2699615 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatulence treatment
Number of subjects: 116
Study 2699615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 2699615 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Curcuma domestica Val., Flatulence, Placebo)
Number of subjects: 116
Study 769971 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388)
Number of subjects: 0
Study 769971 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388) with other drugs
Number of subjects: 0
Study 769971 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388) as an adjuvant to standard surgical therapy
Number of subjects: 0
Study 30728950 — intervention group
Group type: EXPERIMENTAL
Intervention: Full version of Smoke Free app
Number of subjects: 28112
Study 30728950 — intervention group
Group type: COMPARATOR
Intervention: Reduced version of Smoke Free app
Number of subjects: 28112
Study 26972526 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement imitation therapy (experimental group)
Number of subjects: 16
Study 26972526 — intervention group
Group type: COMPARATOR
Intervention: Control group (no imitation training)
Number of subjects: 16
Study 24331278 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental training
Number of subjects: 217
Study 24331278 — intervention group
Group type: EXPERIMENTAL
Intervention: Family feedback
Number of subjects: 217
Study 24331278 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 217
Study 23039993 — intervention group
Group type: EXPERIMENTAL
Intervention: Single umbilical incision laparoscopic surgery (SILS)
Number of subjects: 50
Study 23039993 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (CL)
Number of subjects: 50
Study 20413299 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab treatment in KRAS wild type patients
Number of subjects: 559
Study 20413299 — intervention group
Group type: COMPARATOR
Intervention: No cetuximab treatment in KRAS wild type patients (control group)
Number of subjects: 559
Study 20413299 — intervention group
Group type: EXPERIMENTAL
Intervention: Other markers (PIK3CA mutation, loss of PTEN expression, EGFR GCN, HER2 GCN)
Number of subjects: 559
Study 17905952 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal debridement technique
Number of subjects: 49
Study 17905952 — intervention group
Group type: COMPARATOR
Intervention: Conventional clearance technique
Number of subjects: 49
Study 16135348 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine plus fentanyl (BF) 3 microg/mL
Number of subjects: 70
Study 16135348 — intervention group
Group type: COMPARATOR
Intervention: 0.15% ropivacaine (R)
Number of subjects: 70
Study 12239234 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 or 80 mg)
Number of subjects: 24
Study 12239234 — intervention group
Group type: COMPARATOR
Intervention: Fosinopril (20 mg)
Number of subjects: 24
Study 10065895 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (50 IU/kg)
Number of subjects: 23
Study 7733424 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention (2 hours of behaviorally based education on dietary changes)
Number of subjects: 40
Study 7733424 — intervention group
Group type: COMPARATOR
Intervention: Usual intervention (5 minutes of counseling)
Number of subjects: 40
Study 2126738 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide + Flutamide (L + F)
Number of subjects: 617
Study 2126738 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide (L) alone
Number of subjects: 617
Study 7021263 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin administered twice daily (50 mg/kg body-weight/day)
Number of subjects: 34
Study 7021263 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin administered four times daily (50 mg/kg body-weight/day)
Number of subjects: 34
Study 31398066 — intervention group
Group type: COMPARATOR
Intervention: Facemask therapy (FM group)
Number of subjects: 40
Study 31398066 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask therapy with a miniscrew (FM+MS group)
Number of subjects: 40
Study 31101920 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity behavioral change intervention delivered by physical therapists in 18 sessions over 12 months
Number of subjects: 120
Study 31101920 — intervention group
Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 120
Study 31101920 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity behavioral change intervention
Number of subjects: 120
Study 31101920 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT participants (n = 60)
Number of subjects: 120
Study 27885746 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced couple-focused group (ECG) intervention
Number of subjects: 302
Study 27885746 — intervention group
Group type: COMPARATOR
Intervention: Couples' support group
Number of subjects: 302
Study 27885746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (ECG and support group)
Number of subjects: 302
Study 27885746 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG intervention
Number of subjects: 302
Study 27885746 — intervention group
Group type: COMPARATOR
Intervention: Support group
Number of subjects: 302
Study 26068921 — intervention group
Group type: EXPERIMENTAL
Intervention: paper-based Map Me
Number of subjects: 0
Study 26068921 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based Map Me
Number of subjects: 0
Study 26068921 — intervention group
Group type: COMPARATOR
Intervention: no information (control)
Number of subjects: 0
Study 24521647 — intervention group
Group type: EXPERIMENTAL
Intervention: Biapenem (300 mg every 12 h)
Number of subjects: 272
Study 24521647 — intervention group
Group type: COMPARATOR
Intervention: Meropenem (500 mg every 8 h)
Number of subjects: 272
Study 21988649 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulated running (ten 3-min bouts with 30 min rest between bouts)
Number of subjects: 10
Study 21988649 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous running (one 30-min bout)
Number of subjects: 10
Study 21988649 — intervention group
Group type: COMPARATOR
Intervention: Control (resting)
Number of subjects: 10
Study 21988649 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulated running and Continuous running
Number of subjects: 10
Study 19300186 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program
Number of subjects: 0
Study 19300186 — intervention group
Group type: COMPARATOR
Intervention: Traditional patient care (Control)
Number of subjects: 0
Study 17542199 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Toothpaste
Number of subjects: 76
Study 17542199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 14766425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vesical pacing with parameters: amplitude of 5 mA, pulse width of 200 ms, frequency 20% higher than basal vesical waves
Number of subjects: 36
Study 14766425 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pacing)
Number of subjects: 36
Study 11743708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (active treatment)
Number of subjects: 29
Study 11743708 — intervention group
Group type: COMPARATOR
Intervention: Traditional symptom alleviation (passive treatment)
Number of subjects: 29
Study 9924711 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally once daily for 3 days (n = 150)
Number of subjects: 303
Study 9924711 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav 625 mg orally three times daily for 5-10 days (n = 153)
Number of subjects: 303
Study 9924711 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 303
Study 9419764 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen alone (0.625 mg conjugated equine estrogen for 6 months)
Number of subjects: 28
Study 9419764 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen with progestin (0.625 mg conjugated equine estrogen with 10 mg medroxyprogesterone acetate for 10 days each month for 6 months)
Number of subjects: 28
Study 9419764 — intervention group
Group type: COMPARATOR
Intervention: Insulin tolerance test (ITT) and frequently sampled intravenous glucose tolerance test (FSIVGTT)
Number of subjects: 28
Study 2954477 — intervention group
Group type: EXPERIMENTAL
Intervention: Transluminal angioplasty
Number of subjects: 0
Study 2954477 — intervention group
Group type: COMPARATOR
Intervention: Surgical revision
Number of subjects: 0
Study 31509319 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish skin grafts
Number of subjects: 170
Study 31509319 — intervention group
Group type: COMPARATOR
Intervention: dHACM
Number of subjects: 170
Study 29661378 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside 0.5 μg kg-1 min-1 during RS-ketamine infusion
Number of subjects: 0
Study 29661378 — intervention group
Group type: COMPARATOR
Intervention: Placebo during RS-ketamine infusion
Number of subjects: 0
Study 29661378 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside 0.5 μg kg-1 min-1 during esketamine infusion
Number of subjects: 0
Study 29661378 — intervention group
Group type: COMPARATOR
Intervention: Placebo during esketamine infusion
Number of subjects: 0
Study 28814317 — intervention group
Group type: EXPERIMENTAL
Intervention: Collabri model for collaborative care
Number of subjects: 1092
Study 28814317 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 1092
Study 26223033 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized feedback during laparoscopic simulator training
Number of subjects: 16
Study 26223033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 16
Study 23356580 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 26
Study 23356580 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 26
Study 16643394 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D devices
Number of subjects: 501
Study 16643394 — intervention group
Group type: EXPERIMENTAL
Intervention: DER testing
Number of subjects: 501
Study 14653298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nupro coarse prophy paste
Number of subjects: 20
Study 14653298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nupro medium prophy paste
Number of subjects: 20
Study 14653298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nupro fine prophy paste
Number of subjects: 20
Study 14653298 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro prophy paste
Number of subjects: 20
Study 14653298 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated toothbrushing
Number of subjects: 20
Study 14653298 — intervention group
Group type: COMPARATOR
Intervention: Baseline and disk treatment
Number of subjects: 20